Global Medical Foods Market By Overview
Medical Food Market accounted for US$ 27.3 billion in 2024 and is estimated to be US$ 41.6 billion by 2034 and is anticipated to register a CAGR of 4.7%.
Medical foods must suits all applicable FDA requirements for foods. This includes the regulations concerning current good manufacturing practices (cGMPs), Registration of Food Facilities, and, if applicable, those specific to the merchandise formulation and processing. Samples of formula- and processing-specific regulations include those for thermally processed low-acid foods packaged in hermetically sealed containers, acidified foods, and emergency permit control. Albeit the extent of industry experience within the cGMP and internal control procedures necessary to supply medical foods (i.e., products that contain nutrients within a narrow range of declared label values) increased within the decade directly following the establishment of the statutory definition of medical food, the agency felt it necessary to make compliance programs specifically designed for medical foods. Medical foods are complex formulated products requiring sophisticated and exacting technology like that utilized in the manufacture of infant formulas and medicines. Moreover, the populations that consume such foods are often extremely vulnerable, like pediatric patients at periods of growth and development or the elderly. For these reasons, the FDA published its Medical Foods Compliance Program for domestic and imported products as a part of the agency’s Compliance Program Guidance Manual. This program, which the FDA has explicitly stated may be a “high priority” due to the “susceptible population that the products are intended,” remains in effect.
Global Medical Foods Market By Drivers & Restraints
Increase in geriatric population
Increase in geriatric population as well as rise in burden of chronic diseases around the globe is the major driving factor for the target market growth. For instance, according to a data published by Partnership to fight chronic disease in 2017, 60% had at least one chronic condition and 42% had more than one chronic condition in 2014. However, shifting trend of direct selling to customer via e-commerce platform is anticipated to hinder the target market growth over the forecast period.
Demand for medical foods is increasing
Nevertheless, demand for medical foods is increasing for dietary management of CKD, which in turn is creating lucrative growth opportunities for the target market.
Global Medical Foods Market By Segmentations & Regional Insights
The Medical Food Market report segments the market on the basis of route of administration, product, application, and region.
Based on product type, the target market is classified into Devices & Pumps (Syringe Infusion Pumps, Insulin Infusion Pumps, Volumetric Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia Pumps, Implantable Infusion Pumps, and Enteral Infusion Pumps) and Accessories & Disposables (Infusion Catheters, Valves, IV sets, Cannulas, Tubing, and Needles). Based on application, the Global Medical Food Market is segmented into Diabetes, Gastroenterology, Analgesia & Pain Management, Chemotherapy, and Pediatrics & Neonatology. Based on end-user, the Global Medical Food Market is segmented into Hospitals, Home Care, and Ambulatory Surgical Centers (ASCs).
Regional Insights:
For detailed understanding of market dynamics, North America dominated the worldwide market with a revenue share of 29.9% in 2020. The key factors contributing to the very best revenue share include the presence of key market players and high revenue generated by these players during this region. Additionally, strategic initiatives by players, increasing prevalence of chronic conditions, and rising adoption of medical foods by healthcare professionals and patients are other factors supporting the regional market growth.
Attribute |
Details |
Base year for estimation |
2023 |
Forecast period |
2024 – 2034 |
Market representation |
Revenue in USD Million & CAGR from 2024 – 2034 |
Market Segmentation |
By Route of Administration- Oral and Enteral By Product- Pills and Powder By Application- Retail, Online, and Institutional |
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Detailed Segmentation:
Global Medical Food Market, By Region:
-
-
- North America
- North America Global Medical Food Market, By Route of Administration
- North America Global Medical Food Market, By Product
- North America Global Medical Food Market, By Application
- North America Global Medical Food Market, By Country
- Canada
- Europe
- Europe Global Medical Food Market, By Route of Administration
- Europe Global Medical Food Market, By Product
- Europe Global Medical Food Market, By Application
- Europe Global Medical Food Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Asia Pacific Global Medical Food Market, By Route of Administration
- Asia Pacific Global Medical Food Market, By Product
- Asia Pacific Global Medical Food Market, By Application
- Asia Pacific Global Medical Food Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Latin America Global Medical Food Market, By Route of Administration
- Latin America Global Medical Food Market, By Product
- Latin America Global Medical Food Market, By Application
- Latin America Global Medical Food Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Middle East & Africa Global Medical Food Market, By Route of Administration
- Middle East & Africa Global Medical Food Market, By Product
- Middle East & Africa Global Medical Food Market, By Application
- Middle East & Africa Global Medical Food Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- North America
-
Global Medical Foods Market By Competitive Landscape & Key Players
Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the Global Medical Food Market. Key players operating in the global medical foods market include, Danone, Nestle, Abbott, Targeted Medical Pharma Inc., Primus Pharmaceuticals Inc., Mead Johnson & Company LLC, and Fresenius Kabi AG.
Global Medical Foods Market By Company Profile
- Danone
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Nestle
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Abbott
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Targeted Medical Pharma Inc.
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Medical International Limited
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Primus Pharmaceuticals Inc.
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Mead Johnson & Company LLC
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Fresenius Kabi AG
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
Global Medical Foods Market By Highlights
FAQs
The Global Medical Food Market report segments the market on the basis of route of administration, product, application, and region.
Increase in geriatric population as well as rise in burden of chronic diseases around the globe is the major driving factor for the target market growth.
North America dominated the worldwide market with a revenue share of 29.9% in 2020.
Key players operating in the global medical foods market include, Danone, Nestle, Abbott, Targeted Medical Pharma Inc., Primus Pharmaceuticals Inc., Mead Johnson & Company LLC, and Fresenius Kabi AG.